Executives also cite NIH and FDA uncertainty, external reference pricing, tariffs, and research funding cuts as major threatsWashington, DC, May 08, 2025 (GLOBE NEWSWIRE) -- A new survey conducted by ...

Trials are still ongoing and the results have been mixed, but the supplement is easily available for a few pence ...

Two bills seeking to establish regulation and criminal penalties related to illicit pill press machines will get their first ...

The 'pill penalty,' an unintended consequence of the IRA, has led to a disparity in investment for research and development ...

Released via Easy Life Records, it sees the Ontario-based sibling duo deliver a searing shoegaze anthem. Speaking on ‘Pill To Swallow’, they have shared: “Pill To Swallow is a rallying cry for ...

Lilly intends to submit for approval of the pill for weight management by the end of this year and diabetes in 2026. Not to be outdone, chief rival Novo Nordisk revealed Saturday that it has already ...

Investing.com -- Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron, which ...

He set up rotary tablet pill presses on his property near Alto to create hundreds of thousands of counterfeit pills laced with methamphetamine. These pills were then sold throughout the United States.

A California biotech company has developed a new pill that could extend a dog’s life. After one year of the groundbreaking clinical trial, the pill cleared a major FDA hurdle. More than 1,000 ...

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective in treating obesity and diabetes. The drug, developed by Eli Lilly and ...

Illustration: Elizabeth Smelov The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes ...